NCT01024699View on ClinicalTrials.gov

XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis.

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Spondylolisthesis
Trial Locations (9)

27710

Duke University Medical Center, Durham

31405

St. Joseph's/Candler Health System, Savannah

32204

St. Vincent-Jacksonville, Jacksonville

34747

Celebration Florida Hospital, Kissimmee

42003

Northwest Orthopaedic Specialists, P.S., Paducah

55454

Orthopaedic Clinic-Riverside Campus, University of Minnesota, Minneapolis

77030

The Methodist Hospital, Houston

99208

Northwest Orthopaedic Specialists, P.S., Spokane

99352

Spine and Sports Institute, Richland

Sponsors

Lead Sponsor

NuVasive
All Listed Sponsors
lead

NuVasive

INDUSTRY

NCT01024699 - XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis. | Biotech Hunter | Biotech Hunter